Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191

Epidemiology of Invasive Group A Streptococcal Infections in the United States, 2005–2012

(2016) George E. Nelson et al.   CLINICAL INFECTIOUS DISEASES

Status of research and development of vaccines for Streptococcus pyogenes

(2016) Andrew C. Steer et al.   VACCINE

Interleukin-17A Contributes to the Control of Streptococcus pyogenes Colonization and Inflammation of the Female Genital Tract

(2016) Alison J. Carey et al.   Scientific Reports

Epidemiology of Invasive Group A Streptococcal Disease in Alaska, 2001 to 2013

(2015) Karen Rudolph et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

(2014) M. J. Walker et al.   CLINICAL MICROBIOLOGY REVIEWS

A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for Molecular Typing and Vaccine Development

(2014) Martina Sanderson-Smith et al.   JOURNAL OF INFECTIOUS DISEASES

Regulation of NF-κB by TNF family cytokines

(2014) Matthew S. Hayden et al.   SEMINARS IN IMMUNOLOGY

Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India

(2014) Deepak Kumar Arya et al.   Journal of Infection in Developing Countries

Potential coverage of a multivalent M protein-based group A streptococcal vaccine

(2013) James B. Dale et al.   VACCINE

Identification of Potential Universal Vaccine Candidates against Group A Streptococcus by Using High Throughput in Silico and Proteomics Approach

(2012) Abhinay Sharma et al.   JOURNAL OF PROTEOME RESEARCH

Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case

(2012) Giuliano Bensi et al.   MOLECULAR & CELLULAR PROTEOMICS

The Hypervariable Region of Streptococcus pyogenes M Protein Escapes Antibody Attack by Antigenic Variation and Weak Immunogenicity

(2011) Jonas Lannergård et al.   Cell Host & Microbe

Streptococcus pyogenesM49 Plasminogen/Plasmin Binding Facilitates Keratinocyte Invasion via Integrin-Integrin-linked Kinase (ILK) Pathways and Protects from Macrophage Killing

(2011) Nikolai Siemens et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Streptococcal Pharyngitis

(2011) Michael R. Wessels   NEW ENGLAND JOURNAL OF MEDICINE

New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci

(2011) James B. Dale et al.   VACCINE

The M protein of group A Streptococcus is a key virulence factor and a clinically relevant strain identification marker

(2011) David Metzgar et al.   Virulence

Type I Interferon Production Induced by Streptococcus pyogenes-Derived Nucleic Acids Is Required for Host Protection

(2011) Nina Gratz et al.   PLoS Pathogens

Novel Conserved Group A Streptococcal Proteins Identified by the Antigenome Technology as Vaccine Candidates for a Non-M Protein-Based Vaccine

(2010) A. Fritzer et al.   INFECTION AND IMMUNITY

Large scale multiplex PCR improves pathogen detection by DNA microarrays

(2009) Maria Palka-Santini et al.   BMC MICROBIOLOGY

Seven‐Year Surveillance of North American Pediatric Group A Streptococcal Pharyngitis Isolates

(2009) Stanford T. Shulman et al.   CLINICAL INFECTIOUS DISEASES

Effects of Streptococcal Pyrogenic Exotoxin B on Pathogenesis of Streptococcus pyogenes

(2008) Chuan Chiang-Ni et al.   JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION